Self‐Assembling Peptide as a Potential Carrier for Hydrophobic Anticancer Drug Ellipticine: Complexation, Release and In Vitro Delivery
- 29 December 2008
- journal article
- research article
- Published by Wiley in Advanced Functional Materials
- Vol. 19 (1) , 74-83
- https://doi.org/10.1002/adfm.200800860
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Modification of Hydrophilic and Hydrophobic Surfaces Using an Ionic-Complementary PeptidePLOS ONE, 2007
- Surface-Assisted Assembly of an Ionic-Complementary Peptide: Controllable Growth of NanofibersJournal of the American Chemical Society, 2007
- Enhanced permeability and retention of macromolecular drugs in solid tumors: A royal gate for targeted anticancer nanomedicinesJournal of Drug Targeting, 2007
- Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarctionProceedings of the National Academy of Sciences, 2006
- The use of cell-penetrating peptides for drug deliveryDrug Discovery Today, 2004
- Nanoparticles in cancer therapy and diagnosisAdvanced Drug Delivery Reviews, 2002
- Therapeutic cancer targeting peptidesPeptide Science, 2002
- Use of micellar media for the fluorimetric determination of ellipticine in aqueous solutionsJournal of Pharmaceutical and Biomedical Analysis, 1996
- Self-complementary oligopeptide matrices support mammalian cell attachmentBiomaterials, 1995
- Phase II study of 9-hydroxy-2N-methylellipticinium acetateEuropean Journal of Cancer and Clinical Oncology, 1984